-
摘要: 非酒精性脂肪肝病(NAFLD)是目前世界上最常见的肝脏和代谢疾病，最新证据表明，NAFLD与心律失常的风险密切相关，独立于其他常规的心脏代谢合并症。机制研究表明，与NAFLD相关的病理生理改变可能潜在地引发心脏的结构、电生理和自主神经重构，促进心律失常的发生。然而，其导致的患病率激增却未受到重视。本文阐述了NAFLD与心房颤动、室性心律失常及心脏传导缺陷疾病相关性的临床证据和潜在的病理生理机制，强调NAFLD可能是心律失常发生发展的独立危险因素和潜在驱动力。Abstract: Non-……alcoholic fatty liver disease(NAFLD) is the most common liver and metabolic disease worldly. Emerging evidences suggest that NAFLD is strongly associated with the risk of cardiac arrhythmias, independent of other conventional cardiometabolic comorbidities. Mechanistic studies imply that pathophysiological alterations associated with NAFLD may trigger structural, electrophysiological, and autonomic remodeling of the heart, promoting the development of arrhythmias. However, little attention has been paid to the pathophysiological association between NAFLD and cardiac arrhythmias. This comment describes the clinical evidence and potential pathophysiological mechanisms underlying the association of NAFLD with atrial fibrillation, ventricular arrhythmias, and cardiac conduction defect disease, highlighting that NAFLD may be an independent risk factor and a potential driver for the development of arrhythmias.
-
-
[1] Chen J, Mei Z, Wang Y, et al. Causal effect of non-alcoholic fatty liver disease on atrial fibrillation[J]. Eur J Intern Med, 2022, 105: 114-117. doi: 10.1016/j.ejim.2022.07.007
[2] Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications[J]. Gut, 2020, 69(9): 1691-1705. doi: 10.1136/gutjnl-2020-320622
[3] Alonso A, Misialek JR, Amiin MA, et al. Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort[J]. Heart, 2014, 100(19): 1511-1516. doi: 10.1136/heartjnl-2014-305756
[4] Schutte R, Whincup PH, Papacosta O, et al. Liver enzymes are not directly involved in atrial fibrillation: a prospective cohort study[J]. Eur J Clin Invest, 2017, 47(8): 583-590. doi: 10.1111/eci.12779
[5] Cai X, Zheng S, Liu Y, et al. Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation[J]. Liver Int, 2020, 40(7): 1594-1600. doi: 10.1111/liv.14461
[6] Mantovani A, Dauriz M, Sandri D, et al. Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis[J]. Liver Int, 2019, 39(4): 758-769. doi: 10.1111/liv.14044
[7] van Kleef LA, Lu Z, Ikram MA, et al. Liver stiffness not fatty liver disease is associated with atrial fibrillation: The Rotterdam study[J]. J Hepatol, 2022, 77(4): 931-938. doi: 10.1016/j.jhep.2022.05.030
[8] Targher G, Valbusa F, Bonapace S, et al. Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes[J]. Nutr Metab Cardiovasc Dis, 2014, 24(6): 663-669. doi: 10.1016/j.numecd.2014.01.005
[9] Hung CS, Tseng PH, Tu CH, et al. Nonalcoholic fatty liver disease is associated with QT prolongation in the general population[J]. J Am Heart Assoc, 2015, 4(7): 110.
[10] Mantovani A, Rigamonti A, Bonapace S, et al. Nonalcoholic fatty liver disease is associated with ventricular arrhythmias in patients with type 2 diabetes referred for clinically indicated 24-hour holter monitoring[J]. Diabetes Care, 2016, 39(8): 1416-1423. doi: 10.2337/dc16-0091
[11] Kunutsor SK, Laukkanen JA, Bluemke DA, et al. Baseline and long-term gamma-glutamyltransferase, heart failure and cardiac arrhythmias in middle-aged Finnish men: Prospective study and pooled analysis of published evidence[J]. Eur J Prev Cardiol, 2016, 23(13): 1354-1362. doi: 10.1177/2047487316644086
[12] Chen X, Zhao X, Wu H, et al. Association of nonalcoholic fatty liver disease with ventricular tachycardia and sinus arrest in patients with Non-ST-segment elevation myocardial infarction[J]. Int Heart J, 2022, 63(5): 814-820. doi: 10.1536/ihj.22-113
[13] İşcen S. RBBB is associated with an increased risk of NAFLD in young healthy individuals[J]. Int J Cardiol, 2013, 168(4): 4056-4057. doi: 10.1016/j.ijcard.2013.07.035
[14] Mantovani A, Rigolon R, Pichiri I, et al. Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus[J]. PLoS One, 2017, 12(10): e0185459. doi: 10.1371/journal.pone.0185459
[15] Mangi MA, Minhas AM, Rehman H, et al. Association of non-alcoholic fatty liver disease with conduction defects on electrocardiogram[J]. Cureus, 2017, 9(3): e1107.
[16] Wijarnpreecha K, Panjawatanan P, Kroner PT, et al. Association between cardiac conduction defect and nonalcoholic fatty liver disease: a systematic review and meta-analysis[J]. Ann Gastroenterol, 2020, 33(6): 661-666.
[17] Chen Z, Liu J, Zhou F, et al. Nonalcoholic fatty liver disease: an emerging driver of cardiac arrhythmia[J]. Circ Res, 2021, 128(11): 1747-1765. doi: 10.1161/CIRCRESAHA.121.319059
[18] Monnerat G, Alarcón ML, Vasconcellos LR, et al. Macrophage-dependent IL-1β production induces cardiac arrhythmias in diabetic mice[J]. Nat Commun, 2016, 7: 13344. doi: 10.1038/ncomms13344
[19] Sawaya SE, Rajawat YS, Rami TG, et al. Downregulation of connexin40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor[J]. Am J Physiol Heart Circ Physiol, 2007, 292(3): H1561-1567. doi: 10.1152/ajpheart.00285.2006
[20] Aschar-Sobbi R, Izaddoustdar F, Korogyi AS, et al. Increased atrial arrhythmia susceptibility induced by intense endurance exercise in mice requires TNFα[J]. Nat Commun, 2015, 6: 6018. doi: 10.1038/ncomms7018
[21] O'Connell RP, Musa H, Gomez MS, et al. Free fatty acid effects on the atrial myocardium: membrane ionic currents are remodeled by the disruption of T-tubular architecture[J]. PLoS One, 2015, 10(8): e0133052. doi: 10.1371/journal.pone.0133052
[22] Adameova A, Shah AK, Dhalla NS. Role of oxidative stress in the genesis of ventricular arrhythmias[J]. Int J Mol Sci, 2020, 21(12): 110. http://www.xueshufan.com/publication/3035525136
[23] Rong H, Huang L, Jin N, et al. Elevated homocysteine levels associated with atrial fibrillation and recurrent atrial fibrillation[J]. Int Heart J, 2020, 61(4): 705-712. doi: 10.1536/ihj.20-099
[24] Couselo-Seijas M, Rodríguez-Mañero M, González-Juanatey JR, et al. Updates on epicardial adipose tissue mechanisms on atrial fibrillation[J]. Obes Rev, 2021, 22(9): e13277.
[25] Houghton D, Zalewski P, Hallsworth K, et al. The degree of hepatic steatosis associates with impaired cardiac and autonomic function[J]. J Hepatol, 2019, 70(6): 1203-1213. doi: 10.1016/j.jhep.2019.01.035
-
计量
- 文章访问数: 2753
- PDF下载数: 948
- 施引文献: 0
下载: